摘要
Abstract
Cancer prevention and control in China face severe challenges.Although targeted therapy and immu-notherapy have made remarkable progress,chemotherapy remains a cornerstone of comprehensive cancer treatment,and its toxic side effects pose a significant challenge in clinical practice.As a compound formulation exhibiting both antitumor and toxicity-reducing effects,Sodium cantharidinate and vitamin B6 injection has been utilized in clinical practice in China for over two decades.However,standardized guidelines for its application remain lacking in routine clinical use.To address this gap,the Lung Cancer Specialty Committee of Chinese Elderly Health Care Association organized a panel of experts to develop this consensus document,drawing on current evidence-based data and accumulated clinical experience.This consensus provides a systematic elaboration of the preparation's pharmacological mechanisms and pharmacokinetic profiles,and offers specific rec-ommendations for its clinical application across various malignancies,including lung cancer and hepatocellular carcinoma.The primary objective of this consensus is to establish standardized guidance for clinicians regarding the appropriate use of Sodium cantharidinate and vitamin B6 injection,thereby promoting its rational application and ultimately enhancing treatment efficacy and quality of life for cancer patients.关键词
斑蝥酸钠维生素B6注射液/专家共识/恶性肿瘤/临床应用Key words
Sodium cantharidinate and vitamin B6 injection/Expert consensus/Malignant tumors/Clinical application
